Stock Update (NYSE:A): Agilent Technologies and Applied Spectral Imaging Announce Co-Marketing Agreement for Fluorescence In Situ Hybridization

[Business Wire] – Agilent Technologies Inc. and Applied Spectral Imaging today announced they have entered into an agreement to jointly market ASI’s most advanced GenASIs imaging platforms and Agilent’s fluorescence in situ hybridization products and solutions, including its Dako Omnis instrument for automated FISH sample processing. Read more on this. Agilent Technologies, Inc. (A) , currently valued at $13.01B, began trading this morning at $39.89. Today, shares have traded between $39.49 and $40.11 per share and has traded between $33.12 and $43.59 over the past year. A shares are currently priced at 21.63x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 6.09x earnings multiple. And for passive income investors, the company pays shareholders $0.46 per share annually in dividends, yielding 1.14%. In a review of the consensus earnings estimate this quarter, 14 sell-side analysts are looking at $0.39 per share, which would be $0.01 better than the year-ago quarter and a $0.04 sequential decrease. Investors should also note that the full-year EPS estimate of $1.86 is a $0.12 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $979.62 Million. If realized, that would be a 1.73% increase over the year-ago quarter. More recently, Deutsche Bank Initiated A at Hold (Jan 7, 2016). Previously, UBS Initiated A at to Neutral. The average price target for A shares by the analysts covering the stock is $44.93, which is 12.63% above where the stock opened this morning. See more in (NYSE:A) Similar Articles: Stock Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies to Sponsor USCAP 2016 Company Update: Agilent Technologies Inc (NYSE:A) – TRADE NEWS: Agilent Technologies and 10x Genomics Announce Collaboration to Develop a Premium Exome Stock Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Signs Instrument Control Exchange Agreement with Thermo Fisher Scientific